Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rivera MP"" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł:
Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians
Autorzy:
Henderson LM
Jones LM
Marsh MW
Brenner AT
Goldstein AO
Benefield TS
Greenwood-Hickman MA
Molina PL
Rivera MP
Reuland DS
Pokaż więcej
Temat:
lung neoplasms
mass screening
physician behavior
surveys and questionnaires
Public aspects of medicine
RA1-1270
Źródło:
Risk Management and Healthcare Policy, Vol Volume 10, Pp 189-195 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/opinions-practice-patterns-and-perceived-barriers-to-lung-cancer-scree-peer-reviewed-article-RMHP; https://doaj.org/toc/1179-1594
Dostęp URL:
https://doaj.org/article/3f22aa00d31147a18295bbf559e18b86  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
Autorzy:
Mazzone P; Department of Pulmonary Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, OH, United States of America.
Dotson T; Division of Pulmonary and Critical Care, Wake Forest Baptist Health, Winston-Salem, NC, United States of America.
Wahidi MM; Division of Pulmonary, Allergy & Critical Care Medicine, Duke University Medical Center, Durham, NC, United States of America.
Bernstein M; Stamford Health Medical Group, Pulmonary, Stamford Hospital, Stamford, CT, United States of America.
Lee HJ; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
Feller Kopman D; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
Yarmus L; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
Whitney D; Head of Early Detection Lung Cancer Initiative, Johnson & Johnson, Boston, MA, United States of America.
Stevenson C; Head of Pharmaceutical Sciences, Lung Cancer Initiative, Johnson & Johnson, London, United Kingdom.
Qu J; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
Johnson M; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
Walsh PS; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
Huang J; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
Lofaro LR; Clinical Operations, Veracyte, Inc, San Francisco, CA, United States of America.
Bhorade SM; Medical Affairs, Veracyte, Inc, San Francisco, CA, United States of America.
Kennedy GC; Research and Development, Clinical Operations, Medical Affairs, Veracyte, Inc, South San Francisco, CA, United States of America.
Spira A; Division of Pulmonary and Critical Care Medicine, Boston University Medical Center, Boston, MA, United States of America.
Rivera MP; Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Pokaż więcej
Corporate Authors:
AEGIS Study Team
Percepta Registry Investigators
Źródło:
PloS one [PLoS One] 2022 Jul 13; Vol. 17 (7), pp. e0268567. Date of Electronic Publication: 2022 Jul 13 (Print Publication: 2022).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Bronchoscopy*/methods
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Biopsy ; Chromosome Mapping ; Humans ; Respiratory Mucosa
Czasopismo naukowe
Tytuł:
NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis.
Autorzy:
Hernández-Rivera MP; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Ramírez-Ramírez A; Departamento de Infectología e Inmunología, Instituto Nacional de Perinatología, Montes Urales 800, 11000 Mexico City, Mexico.
Chiñas-Pérez A; H. Ayuntamiento de Calakmul, Halaltun, 24640 Xpujil, CAM, Mexico.
Monroy-Ostria A; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Cancino-Díaz ME; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Hernández-Montes O; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2016; Vol. 2016, pp. 7951285. Date of Electronic Publication: 2016 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Cation Transport Proteins/*genetics
Genetic Predisposition to Disease/*epidemiology
Genetic Predisposition to Disease/*genetics
Leishmaniasis, Cutaneous/*epidemiology
Leishmaniasis, Cutaneous/*genetics
Polymorphism, Single Nucleotide/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Genetic Markers/genetics ; Humans ; Leishmaniasis, Cutaneous/diagnosis ; Male ; Mexico/epidemiology ; Middle Aged ; Prevalence ; Reproducibility of Results ; Risk Factors ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Study of cutaneous leishmaniasis in the State of Campeche (Yucatan Peninsula), Mexico, over a period of two years.
Autorzy:
Hernández-Rivera MP; Escuela Nacional de Ciencias Biologicas, Instituto Politécnico Nacional, México, Distrito Federal, México.
Hernández-Montes O; Escuela Nacional de Ciencias Biologicas, Instituto Politécnico Nacional, México, Distrito Federal, México.
Chiñas-Pérez A; Honorable Ayuntamiento de Calakmul, Campeche, México.
Batiza-Avelar JM; Honorable Ayuntamiento de Calakmul, Campeche, México.
Sánchez-Tejeda G; Secretaria de Salud, México, Distrito Federal, México.
Wong-Ramírez C; Escuela Nacional de Ciencias Biologicas, Instituto Politécnico Nacional, México, Distrito Federal, México.
Monroy-Ostria A; Escuela Nacional de Ciencias Biologicas, Instituto Politécnico Nacional, México, Distrito Federal, México.
Pokaż więcej
Źródło:
Salud publica de Mexico [Salud Publica Mex] 2015 Jan-Feb; Vol. 57 (1), pp. 58-65.
Typ publikacji:
Journal Article
MeSH Terms:
Leishmaniasis, Cutaneous/*epidemiology
Adult ; Animals ; Antiprotozoal Agents/therapeutic use ; Child ; DNA, Protozoan/analysis ; Disease Reservoirs ; Female ; Geography, Medical ; Humans ; Leishmania braziliensis/isolation & purification ; Leishmania mexicana/isolation & purification ; Leishmaniasis, Cutaneous/parasitology ; Male ; Meglumine/therapeutic use ; Meglumine Antimoniate ; Mexico/epidemiology ; Organometallic Compounds/therapeutic use ; Prevalence ; Remission Induction ; Rodentia/parasitology
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies